JPRN-UMIN000023139
Completed
未知
Evaluation of the effect of epidural anesthesia on aute lung injury induced by one lung ventilation in patients undergoing lobectomy for lung cancer - The effect of epidural anesthesia on acute lung injury induced by one lung ventilation
Conditionslung cancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- lung cancer
- Sponsor
- Keio University School of Medicine
- Enrollment
- 60
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Heart disease with NYHA 2\-4 PaO2 less than 60mmHg under room air FEV1\.0% less than 50% Platelet count less than 100000/mm3 Coagulation disorder (PT\-INR \> 1\.5\)
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Epidural anesthesia beginning time and Labor progression and delivery typeIRCT20140111016161N6Tehran University of Medical Sciences426
Recruiting
Phase 3
Epidural Anaesthesia and ultrasound guided Hernia block, comparing the haemodynamic stability and adequasy of anaesthesia in geriatric population undergoing inguinal hernia repair using ropivacaine - A one year randomized control trialHealth Condition 1: O- Medical and SurgicalCTRI/2023/08/056477T G Neha Sunil
Completed
Not Applicable
Comparing the effect of epidural anesthesia after operation ; changing the concentration and flow rate of local anesthesia.JPRN-jRCT1091220248Sato Chiyori60
Completed
Not Applicable
Comparison of the effects of epidural injection for labor analgesia: A randomized controlled trialKCT0004389Samsung Medical Center93
Active, not recruiting
Phase 1
The effect of epidural anaesthesia on systemic and local blood flow during stomach cancer operatioThe effect of epidural anaesthesia on systemic and splanchnic hemodynamic during gastroesophageal cancer resectionMedDRA version: 17.0Level: LLTClassification code 10066354Term: Adenocarcinoma of the gastroesophageal junctionSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2014-002036-14-DKars Bo Svendsen